August 27, 2016 6:28 PM ET

Biotechnology

Company Overview of Astex Pharmaceuticals, Inc.

Key Executives for Astex Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Harren Jhoti Ph.D.18 RelationshipsPresident and Director53
Michael Molkentin CPANo RelationshipsChief Financial Officer, Principal Accounting Officer and Corporate Secretary61
Mohammad Azab M.B. ChB., MBA15 RelationshipsChief Medical Officer60
Martin Buckland DPhil, MBANo RelationshipsChief Business Officer61
Michael V. McCullar Ph.D., MBANo RelationshipsSenior Vice President of Business Development--
View More Key Executives

Astex Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Peter J. Fellner Ph.D. 85 RelationshipsVernalis plc73
Harren Jhoti Ph.D. 18 RelationshipsAstex Therapeutics Limited53
Walter J. Lack J.D. 16 RelationshipsSpectrum Laboratories, Inc.68
Charles J. Casamento MBA 67 RelationshipsThe Sage Group, Inc.71
David J. Bearss Ph.D. 14 RelationshipsTolero Pharmaceuticals, Inc.47
View All Board Members

Astex Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee MBA Charles J. Casamento67 Relationships3 Executives
Compensation Committee J.D.Walter J. Lack16 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
380.3K
Bonus
263.8K
Total Short Term Compensation
477.5K
Total Value of Options
33.9M
Compensation as of Fiscal Year
Astex Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Juno Therapeutics, Inc. Announces Resignation of Marc Tessier-Lavigne from the Board of Directors
August 26, 2016 9:11 PM ET
Agios Pharmaceuticals, Inc. Announces Management Changes
August 26, 2016 8:02 PM ET
Tapimmune, Inc. Appoints Michael Loiacono as Chief Financial Officer, Chief Accounting Officer, Secretary and Treasurer
August 25, 2016 12:52 PM ET
OptiBiotix Health plc Announces Executive Changes
August 25, 2016 6:00 AM ET
Pacific Edge Limited Announces Board Changes
August 25, 2016 2:34 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Astex Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.